Halozyme announced recently that Yale researchers have started a 20-patient artificial pancreas study (which is still recruiting) that will test the ability of...
Research
The latest research in type 1 diabetes, type 2 diabetes, prediabetes, and beyond. Here you’ll find information on experimental therapies, new data and results, and scientific findings.
26 readers recommended
On April 24, Hyperion Therapeutics announced that it would acquire Andromeda Biotech. Andromeda is focused on the development of a first-in-class immune therapy for new...
35 readers recommended
TrialNet is bringing their services online, making it easier for people to be screened for type 1 diabetes. Family members of those with type 1 diabetes can answer an...
28 readers recommended
On November 4, JDRF announced a partnership with Pfizer’s Centers for Therapeutic Innovation (CTI) to support what they call promising diabetes research in collaboration...
79 readers recommended
At ADA this year, type 2 drugs for type 1 diabetes show lots of promise. Plus, the latest exciting data on the Medtronic Veo and hypoglycemia.
31 readers recommended
The National Institutes of Health (NIH) recently announced it will provide millions of dollars in funding for the first large-scale clinical trial to determine whether...
84 readers recommended
A whole new approach to treating type 2 diabetes at diagnosis, a new type of metformin, and the benefit of adding a GLP-1 agonist to insulin.
45 readers recommended
You call that an artificial pancreas? The pathway to closed loop system.
34 readers recommended
On July 10, the JDRF and 161 delegates for the Children’s Congress traveled to Capitol Hill inWashington, D.C. to call for support of type 1 diabetes research funding...
32 readers recommended
On June 5, Xeris Pharmaceuticals announced that the first patient had been dosed in its phase 2 clinical trial , which is testing “mini-dose” glucagon for the treatment...
28 readers recommended
Twitter Summary: @DpT1D of the #helmsleytrust talks about need 4 philanthropic support in #T1D in inspiring Wired op-ed David Panzirer , a trustee of the Helmsley...
39 readers recommended
Debates in type 1 diabetes – what is the future of technology and what is a “cure"? Part three of our interview with David Panzirer and Dana Ball.
21 readers recommended
On September 24, JAMA published a paper on long-term trends in the number of people with diabetes in the United States from 1980 to 2012. The results showed a leveling-...
69 readers recommended
Advances for type 2 diabetes at The American Diabetes Association 74th Scientific Sessions
25 readers recommended
Twitter summary: A new technology from Stanford has potential for easier, more accurate, & cheaper diagnosis for #t1d A team of Stanford University researchers, with...
29 readers recommended
The T1D Exchange: a bold vision to advance the field of type 1 diabetes – part four of our interview with David Panzirer and Dana Ball.
30 readers recommended
The hope and hype of curing diabetes with stem cells – our take on the Harvard research and more.
24 readers recommended
Why aren’t there more therapies and devices for pediatric patients? Find out why and what we can do to help.
31 readers recommended
Can artificial sweeteners contribute to weight gain and worse diabetes control? A remarkable new study on the role of gut bacteria...
31 readers recommended
We sit down with new JDRF CEO Derek Rapp for his first interview as CEO – find out what he's excited about for JDRF's future!